Management of cardiogenic shock complicating acute myocardial infarction: A review

Area of Science:

• Cardiology
• Critical Care Medicine

Background:

• Acute myocardial infarction (MI) complicated by cardiogenic shock (CS) carries a high mortality rate.
• Current treatment strategies for MI with CS lack robust evidence.
• Advances in percutaneous coronary interventions have not significantly reduced mortality in CS patients.

Purpose of the Study:

• To provide a comprehensive overview of cardiogenic shock complicating MI.
• To update current treatment options for MI-induced cardiogenic shock.
• To discuss the evidence supporting various therapeutic interventions.

Main Methods:

• Review of existing literature on cardiogenic shock in acute myocardial infarction.
• Discussion of current therapeutic modalities including pharmacotherapy and mechanical support.
• Analysis of treatment efficacy and long-term outcomes.

Main Results:

• High mortality persists in patients with MI complicated by CS.
• Evidence supporting many routine therapies is limited.
• A range of treatment options are available, including inotropes, vasopressors, revascularization, and mechanical circulatory support.

Conclusions:

• Cardiogenic shock remains a critical complication of MI with limited treatment options.
• Further research is needed to establish evidence-based therapies for MI-induced CS.
• Comprehensive management strategies are essential for improving outcomes in these high-risk patients.